Prevalence and management of abdominal cramping and pain: a multinational survey

@article{Quigley2006PrevalenceAM,
  title={Prevalence and management of abdominal cramping and pain: a multinational survey},
  author={Eamonn M. M. Quigley and Giles Richard Locke and Stefan A. Mueller-Lissner and Luiz Gonçalves Paulo and Guido N. J. Tytgat and I Helfrich and Eckhard Schaefer},
  journal={Alimentary Pharmacology \& Therapeutics},
  year={2006},
  volume={24}
}
Though functional gastrointestinal complaints are recognised as being common throughout the world, there have been few comparative studies of prevalence. 
Drug treatment of chronic‐intermittent abdominal cramping and pain: a multi‐national survey on usage and attitudes
Aliment Pharmacol Ther 2010; 32: 472–477
The effects of ageing on the onset and disappearance of unexplained abdominal pain: a population‐based study
The population ≥65 years is rapidly increasing, but remarkably little is known about the natural history of abdominal pain with ageing.
Editorial: Clinical Implications of Diagnosing Irritable Bowel Syndrome: Do All Roads Need to Lead to Rome?
TLDR
The questions raised by this study regarding the importance of making a confident diagnosis, conveying it to patients and their implications for clinical practice are discussed. Expand
Impact of Irritable Bowel Syndrome upon Female s' Health Related Quality of Life
TLDR
A negative impact of IBS on Health Related Quality of life in females at 28-37 years old, widow were lowered quality of life, the IBS were negative impact on government employed females. Expand
Pharmacotherapy Update: Hyoscine Butylbromide in the Treatment of Abdominal Spasms:
TLDR
Evidence exists to support Hyoscine butylbromide use in the management of non-specific colicky abdominal pain; irritable bowel syndrome; labor and delivery; dysmenorrhea; as an adjunct in the therapy of late stage cancer patients with inoperable bowel malignancies; and to facilitate improved resolution in certain imaging techniques. Expand
Understanding and treating abdominal pain and spasms in organic gastrointestinal diseases: inflammatory bowel disease and biliary diseases.
  • G. Makharia
  • Medicine
  • Journal of clinical gastroenterology
  • 2011
TLDR
The aim of this review was to help physicians to understand the pathophysiology and impact to patients of abdominal pain and spasms in inflammatory bowel disease (IBD) and biliary diseases, and to help in the selection of the most appropriate treatment. Expand
Hyoscine Butylbromide
TLDR
Hyoscine butylbromide was considered beneficial in all of these trials, which supports its use in the treatment of abdominal pain caused by cramping and safety data from clinical trials of this drug are summarized. Expand
Irritable bowel syndrome in Upper Egypt : The role of intestinal parasites and evidence of Th 2 response
1687-1979/$ see front matter 2010 Arab Journal o doi:10.1016/j.ajg.2010.04.011 * Corresponding author. Tel.: +20 88 2316205. E-mail address: sosaoud@hotmail.com (S.S. Abdelm Background and studyExpand
Population-based assessment of gastrointestinal symptoms and diseases: Cappadocia Cohort, Turkey.
TLDR
This first population-based, cross-sectional cohort study revealed that the prevalence of GIS diseases is critically high for optimal public health and special attention must be paid to these diseases while planning health policies and reimbursements. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 21 REFERENCES
The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects
TLDR
To determine the prevalence, symptom pattern and impact of the irritable bowel syndrome, across eight European countries, using a standardized methodology, the aim was to establish a standard methodology and establish a baseline for this study. Expand
Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non‐selected adult population
TLDR
Prevalence of irritable bowel syndrome shows great variation among epidemiological studies, which may be due to different diagnostic criteria, and should be considered as a cause for concern. Expand
The Functional Gastrointestinal Disorders: Diagnosis, Pathophysiology, and Treatment : A Multinational Consensus
TLDR
This book presents a single source of standardized definitions, diagnostic criteria and treatment recommendations forFunctional gastrointestinal disorders, which should no longer need to make a diagnosis of exclusion. Expand
Irritable bowel syndrome – an evidence‐based approach to diagnosis
TLDR
Historically IBS has been viewed by many as a diagnosis of exclusion rather than as a primary diagnosis, and many patients with typical symptoms will undergo an extensive array of diagnostic tests and procedures prior to the eventual diagnosis of IBS. Expand
Prevalence of irritable bowel syndrome: a community survey.
TLDR
Quality of life was significantly reduced in patients with IBS and population-based health surveys will need to supplement the Rome criteria with questions aiming to identify patients formally diagnosed but whose symptoms are currently under control if prevalence is to be reliably estimated. Expand
Irritable bowel syndrome: definition, diagnosis and epidemiology.
  • N. Talley
  • Medicine
  • Bailliere's best practice & research. Clinical gastroenterology
  • 1999
TLDR
The development of acceptable, symptom-based diagnostic criteria has advanced the field, stimulating interest in the pathophysiology and targeted pharmacological therapy, which are essential steps if the disease burden is to be reduced. Expand
Irritable bowel syndrome in the general population.
TLDR
Symptoms consistent with a diagnosis of irritable bowel syndrome are present in almost one quarter of the general population and tend to be associated with a number of other complaints and conditions, some of which may reflect smooth muscle dysfunction. Expand
Towards positive diagnosis of the irritable bowel.
TLDR
The prevention of cot deaths is dependent firstly on the recognition by parents of the significance of certain non-specific symptoms and on their decision to involve the primary care services, and secondly on the efficacy of medical intervention at this stage. Expand
A diagnostic score for the irritable bowel syndrome: Its value in the exclusion of organic disease
TLDR
It is concluded that a detailed history, physical examination, and basic laboratory tests are sufficient in most patients for the positive diagnosis of irritable bowel syndrome and the exclusion of any underlying organic diseases. Expand
Functional bowel disorders and functional abdominal pain
TLDR
A committee consensus approach, including criticism from multinational expert reviewers, was used to revise the diagnostic criteria and update diagnosis and treatment recommendations, based on research results. Expand
...
1
2
3
...